Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

被引：0
|
作者：
Sergio Granados-Principal
Yi Liu
Maria L Guevara
Elvin Blanco
Dong Soon Choi
Wei Qian
Tejal Patel
Angel A Rodriguez
Joseph Cusimano
Heidi L Weiss
Hong Zhao
Melissa D Landis
Bhuvanesh Dave
Steven S Gross
Jenny C Chang
机构：
[1] Methodist Cancer Center,Department of Nanomedicine
[2] Houston Methodist Hospital,Department of Chemistry and Biochemistry
[3] Medical and Health Sciences College,Biostatistics Shared Resource Facility, Markey Cancer Center
[4] Monterrey Institute of Technology,Department of Systems Medicine and Bioengineering
[5] Houston Methodist Research Institute,undefined
[6] Arizona State University,undefined
[7] University of Kentucky,undefined
[8] Houston Methodist Research Institute,undefined
[9] Weill Cornell Medical College,undefined
来源：
Breast Cancer Research | / 17卷
关键词：
Docetaxel; Endoplasmic Reticulum Stress; Amlodipine; iNOS Expression; TNBC Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
    Kumari, Mamta
    Krishnamurthy, Praveen Thaggikuppe
    Sola, Piyong
    CURRENT CANCER DRUG TARGETS, 2020, 20 (08) : 559 - 572
  • [22] Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Kiesel, Ludwig
    BREAST CARE, 2011, 6 (03) : 234 - 239
  • [23] Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
    Deng, Xiyun
    Zheng, Chanjuan
    Tang, Faqing
    Rosol, Thomas J. J.
    Shao, Zhi-Ming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Targeted Therapy Blocks Growth of Triple-Negative Breast Cancer in Mice
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (21): : 2267 - 2267
  • [25] Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer
    Dias, Cristina J.
    Helguero, Luisa
    Faustino, Maria Amparo F.
    MOLECULES, 2021, 26 (24):
  • [26] Sacituzumab govitecan: breakthrough targeted therapy for triple-negative breast cancer
    Weiss, Jennifer
    Glode, Ashley
    Messersmith, Wells A.
    Diamond, Jennifer
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (08) : 673 - 679
  • [27] Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer
    Rhodes, Lyndsay V.
    Tilghman, Syreeta L.
    Boue, Stephen M.
    Wang, Shuchun
    Khalili, Hafez
    Muir, Shannon E.
    Bratton, Melyssa R.
    Zhang, Qiang
    Wang, Guangdi
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    ONCOLOGY LETTERS, 2012, 3 (01) : 163 - 171
  • [28] Combined Photosensitive Gene Therapy Effective Against Triple-Negative Breast Cancer in Mice Model
    Hu, Yixue
    Wang, Dongna
    Zhang, Tianyu
    Lei, Meng
    Luo, Yingnan
    Chen, Zhimeng
    Li, Yuting
    Duan, Dandan
    Zhang, Liefeng
    Zhu, Yongqiang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 1809 - 1825
  • [29] Novel therapy for locally advanced triple-negative breast cancer
    Yamada, Atsuko
    Osada, Shinji
    Tanahashi, Toshiyuki
    Matsui, Satoshi
    Sasaki, Yoshiyuki
    Tanaka, Yoshihiro
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yamaguchi, Kazuya
    Yoshida, Kazuhiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (04) : 1266 - 1272
  • [30] Development of novel combination therapy for triple-negative breast cancer
    Lee, H.
    Lee, K.
    Lee, J.
    Yoon, K.
    Mohammad, A. M.
    Park, H. S.
    Park, J. S.
    Lee, S. -T.
    Sohn, J.
    BREAST, 2019, 44 : S36 - S37
12345